Connection
Jeffrey Sawyer to Myeloablative Agonists
This is a "connection" page, showing publications Jeffrey Sawyer has written about Myeloablative Agonists.
|
|
Connection Strength |
|
|
|
|
|
0.300 |
|
|
|
-
Barlogie B, Tricot G, Haessler J, van Rhee F, Cottler-Fox M, Anaissie E, Waldron J, Pineda-Roman M, Thertulien R, Zangari M, Hollmig K, Mohiuddin A, Alsayed Y, Hoering A, Crowley J, Sawyer J. Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989. Blood. 2008 Jan 01; 111(1):94-100.
Score: 0.300